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To the Editor:
I read with great interest the report by Zalewska-Adamiec
et al. [1] about the 95 patients (89% female) from the
northern-eastern part of Poland who were hospitalised with
takotsubo syndrome (TTS) in the years 2008–2012. The
authors have contrasted the TTS cohort with 101 female
patients with an anterior ST-segment elevation acute my-
ocardial infarction (STEMI), and found that TTS is not a be-
nign condition; it has an in-hospital phase characterised by
serious complications, but long-term outcomes at follow-
up are better than in patients with STEMI. Similar to the
ones with STEMI, the TTS patients had a past medical
history of hypertension (63.2% vs. 68.3%), but a lower
prevalence of diabetes mellitus (DM) (12.6% vs. 29.7%),
and hyperlipidaemia (36.8% vs. 64.4%) [1]. It has recently
been reported that the prevalence of DM is low in patients
with TTS [2], and it has been postulated that this may have
pathophysiological connotations. Accordingly, the under-
lying DM-mediated peripheral neuropathy, with its atten-
dant autonomic nervous system peripheral neuropathy, ex-
erts a halting/ameliorating influence on the autonomic sym-
pathetic nervous system, whose unbridled surge is thought
to trigger TTS. Indeed, even if blood-borne catecholamines
are at the roots of TTS, instead of a surge of the autonomic
sympathetic nervous system, DM is characterised by at-
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tenuated adrenal catecholamine secretion rates [2]. Conse-
quently, it would be contributory if the authors provide us
with some details about their 12 patients with DM who suf-
fered from TTS (type of DM, i.e., DM1 vs. DM2, duration
of the illness, therapy with insulin and/or oral antidiabetic
agents, and presence of DM or autonomic peripheral neu-
ropathy). Also, when one contemplates the pathophysiol-
ogy of TTS, it would be more appropriate to compare TTS
patients with subjects of the general resident population
(real ‘controls’), than patients with coronary artery disease,
or patients admitted with an acute STEMI. Accordingly,
I wonder whether the authors have some information about
the prevalence of DM, particularly in women ≥65 years old,
in the Polish general population, or the population residing
in Bialystok, Podlasie Province.
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